Trial Profile
A Prospective, Sixteen-Week, Double-Blind, Placebo-Controlled, Trial of Seroquel [quetiapine] in Combination With Treatment as Usual in Patients With GAD [generalised anxiety disorder] and Remitted Comorbid Opiate Dependence.
Status:
Suspended
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2013
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Generalised anxiety disorder
- Focus Registrational; Therapeutic Use
- 30 Nov 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 May 2008 New trial record.